Are they from Shire, Barr, Teva, or Ranbaxy?
Adderall is in the news today. Barr Laboratories (Barr) recalled lot #311756 of the powerful psychostimulant, indicating that consumers might receive exceedingly potent dosages due to oversized tablets. To get a better idea of the complex under currents in Big Pharma, let’s discuss the pharmaceutical giant,Teva, a player by acquisition in the Adderall recall: For 7.5 billion dollars, Israeli drug giant, Teva Pharmaceutical Industries (now the world’s largest generic drug manufacturer) acquired Barr Laboratories in 2008. Barr currently owns intellectual property rights to Adderall. The average consumer might not be familiar with Teva as a drug manufacturer. However, due to numerous acquisitions and joint ventures, Teva is huge. As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. Here are several examples of Teva’s acquisitions and agreements: Teva and India’s largest generic drug manufacturer, Ranba
